Results 121 to 130 of about 33,699 (271)

COPD: Optimizing Treatment [PDF]

open access: yes, 2015
A guideline update and an expanded armamentarium have many physicians wondering how best to treat patients with COPD. Chronic obstructive pulmonary disease (COPD) carries a high disease burden. In 2012, it was the 4th leading cause of death worldwide.1,2
Ahmed-Sarwar, Nabila   +2 more
core   +1 more source

Determination of physical and chemical stability in pressurised metered dose inhalers: potential new techniques [PDF]

open access: yes, 2015
INTRODUCTION: Pressurised metered dose inhalers (pMDIs) are subject to rigorous physical and chemical stability tests during formulation. Due to the time and cost associated with product development studies, there is a need for online techniques to fast ...
Boyd, BJ   +4 more
core   +1 more source

Evaluation of the anti-inflammatory effects of β-adrenoceptor agonists on human lung macrophages [PDF]

open access: yes, 2016
The principal mechanism by which bronchodilator β-adrenoceptor agonists act is to relax airways smooth muscle although they may also be anti-inflammatory. However, the extent of anti-inflammatory activity and the cell types affected by these agonists are
Gill, S.K.   +3 more
core   +1 more source

BDP/FF NEXThaler to Improve Asthma Control Status in the Real World: The NEWTON Study

open access: yesJournal of Asthma and Allergy, 2023
Fulvio Braido,1,2 Enrico Arnaboldi,1,2 Sara Barile,3 Luca Cavalieri,4 Eleonora Ingrassia,4 Maria Russo,1,2 Alessio Piraino4 1Respiratory Unit for Continuity of Care, IRCCS, Ospedale Policlinico San Martino, Genova, Italy; 2Department of Internal Medicine
Braido F   +6 more
doaj  

A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease [PDF]

open access: yes, 2015
Peer reviewedPublisher ...
D'Urzo, Anthony   +4 more
core   +2 more sources

Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events (Review) [PDF]

open access: yes, 2009
Background Epidemiological evidence has suggested a link between beta2-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are ...
Cates, CJ, Jaeschke, R, Lasserson, TJ
core   +1 more source

Penggunaan Extrafine Beclometason Diproprionat/Formoterol Fumarat pada PPOK [Combined Extrafine Beclomethason Diproprionat/Formoteral Fumarat in COPD]

open access: yesJurnal Respirasi, 2019
Chronic obstructive pulmonary disease (COPD) is a condition characterised by poorly reversible airflow limitation that is generally progressive and causes serious disability.
Sakinatus Syarifah, Muhammad Amin
doaj   +1 more source

Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. [PDF]

open access: yes, 2014
BACKGROUND: Pharmacological therapy for chronic obstructive pulmonary disease (COPD) is aimed at relieving symptoms, improving quality of life and preventing or treating exacerbations.Treatment tends to begin with one inhaler, and additional therapies ...
Aalbers   +511 more
core   +1 more source

Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study

open access: yesInternational Journal of COPD, 2019
Masakazu Ichinose,1 Yasushi Fukushima,2 Yoshikazu Inoue,3 Osamu Hataji,4 Gary T Ferguson,5 Klaus F Rabe,6 Nobuya Hayashi,7 Hiroshi Okada,7 Mami Takikawa,7 Eric Bourne,8 Shaila Ballal,9 Kiernan DeAngelis,10 Magnus Aurivillius,11 Paul Dorinsky,8 Colin ...
Ichinose M   +14 more
doaj  

Home - About - Disclaimer - Privacy